Published in Anal Bioanal Chem on December 02, 2014
Tissue-Specific Glycosylation at the Glycopeptide Level. Mol Cell Proteomics (2015) 0.89
N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues. Mol Cell Proteomics (2016) 0.80
Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry. Biomolecules (2015) 0.80
Advances in MALDI imaging mass spectrometry of proteins in cardiac tissue, including the heart valve. Biochim Biophys Acta (2017) 0.76
Unlocking Cancer Glycomes from Histopathological Formalin-fixed and Paraffin-embedded (FFPE) Tissue Microdissections. Mol Cell Proteomics (2017) 0.75
A standardized method for lectin microarray-based tissue glycome mapping. Sci Rep (2017) 0.75
Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem (1997) 6.99
MALDI imaging mass spectrometry: molecular snapshots of biochemical systems. Nat Methods (2007) 4.20
Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology (2007) 2.45
High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics (2008) 1.91
Identification of proteins from formalin-fixed paraffin-embedded cells by LC-MS/MS. Lab Invest (2005) 1.63
Mass spectrometry based glycoproteomics--from a proteomics perspective. Mol Cell Proteomics (2010) 1.55
Structural and quantitative analysis of N-linked glycans by matrix-assisted laser desorption ionization and negative ion nanospray mass spectrometry. Anal Biochem (2008) 1.49
Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry. J Proteome Res (2010) 1.47
Fragmentation of negative ions from carbohydrates: part 1. Use of nitrate and other anionic adducts for the production of negative ion electrospray spectra from N-linked carbohydrates. J Am Soc Mass Spectrom (2005) 1.40
Structural analysis of N- and O-glycans released from glycoproteins. Nat Protoc (2012) 1.36
Mass spectrometric analysis of formalin-fixed paraffin-embedded tissue: unlocking the proteome within. Proteomics (2006) 1.30
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use. Int J Gynecol Cancer (2005) 1.26
Focused glycomic analysis of the N-linked glycan biosynthetic pathway in ovarian cancer. Proteomics (2008) 1.17
Glycomics, glycoproteomics and the immune system. Curr Opin Chem Biol (2012) 1.17
MALDI Imaging Mass Spectrometry (MALDI-IMS)-application of spatial proteomics for ovarian cancer classification and diagnosis. Int J Mol Sci (2011) 1.12
Derivatization of sialic acids for stabilization in matrix-assisted laser desorption/ionization mass spectrometry and concomitant differentiation of alpha(2 --> 3)- and alpha(2 --> 6)-isomers. Rapid Commun Mass Spectrom (2009) 1.08
Exploring three-dimensional matrix-assisted laser desorption/ionization imaging mass spectrometry data: three-dimensional spatial segmentation of mouse kidney. Anal Chem (2012) 1.04
Matrix assisted laser desorption ionization imaging mass spectrometry workflow for spatial profiling analysis of N-linked glycan expression in tissues. Anal Chem (2013) 1.01
N-linked glycoproteomic analysis of formalin-fixed and paraffin-embedded tissues. J Proteome Res (2009) 0.99
Concise representation of mass spectrometry images by probabilistic latent semantic analysis. Anal Chem (2008) 0.95
Glycomic profiling of tissue sections by LC-MS. Anal Chem (2013) 0.92
New developments in MALDI imaging for pathology proteomic studies. Curr Pharm Des (2007) 0.92
MALDI imaging mass spectrometry profiling of N-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarrays. PLoS One (2014) 0.91
MRI-compatible pipeline for three-dimensional MALDI imaging mass spectrometry using PAXgene fixation. J Proteomics (2013) 0.85
MALDI mass spectrometry imaging of formalin-fixed paraffin-embedded tissues in clinical research. Histol Histopathol (2014) 0.83
Imaging of N-linked glycans from formalin-fixed paraffin-embedded tissue sections using MALDI mass spectrometry. ACS Chem Biol (2014) 0.82
Matrix-assisted laser desorption/ionization imaging protocol for in situ characterization of tryptic peptide identity and distribution in formalin-fixed tissue. Rapid Commun Mass Spectrom (2013) 0.80
Fragmentation of negative ions from N-linked carbohydrates, part 4. Fragmentation of complex glycans lacking substitution on the 6-antenna. J Mass Spectrom (2010) 0.80
Direct N-glycan profiling in the presence of tryptic peptides on MALDI-TOF by controlled ion enhancement and suppression upon glycan-selective derivatization. Anal Chem (2004) 0.80
EZYprep LC-coupled MALDI-TOF/TOF MS: an improved matrix spray application for phosphopeptide characterisation. Proteomics (2010) 0.78
Internal calibrants allow high accuracy peptide matching between MALDI imaging MS and LC-MS/MS. J Proteomics (2012) 0.77
Improve accuracy and sensibility in glycan structure prediction by matching glycan isotope abundance. Anal Chim Acta (2012) 0.77
Identification of oligosaccharides from histopathological sections by MALDI imaging mass spectrometry. Anal Bioanal Chem (2011) 0.77
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med (2007) 5.28
Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology (2007) 2.71
Blinded test in isolated female rabbit heart reliably identifies action potential duration prolongation and proarrhythmic drugs: importance of triangulation, reverse use dependence, and instability. J Cardiovasc Pharmacol (2003) 1.71
Simultaneous glycan-peptide characterization using hydrophilic interaction chromatography and parallel fragmentation by CID, higher energy collisional dissociation, and electron transfer dissociation MS applied to the N-linked glycoproteome of Campylobacter jejuni. Mol Cell Proteomics (2010) 1.63
GlycoSuiteDB: a curated relational database of glycoprotein glycan structures and their biological sources. 2003 update. Nucleic Acids Res (2003) 1.60
IFNgamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract. Blood (2007) 1.59
Small-scale analysis of O-linked oligosaccharides from glycoproteins and mucins separated by gel electrophoresis. Anal Chem (2002) 1.54
Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. Hepatology (2004) 1.50
Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis (2008) 1.48
Mucin-type O-glycosylation--putting the pieces together. FEBS J (2009) 1.46
Comparison of methods for profiling O-glycosylation: Human Proteome Organisation Human Disease Glycomics/Proteome Initiative multi-institutional study of IgA1. Mol Cell Proteomics (2009) 1.45
Differentiating electrophysiological effects and cardiac safety of drugs based on the electrocardiogram: a blinded validation. Heart Rhythm (2012) 1.44
Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response. J Immunol (2009) 1.43
Cell surface protein glycosylation in cancer. Proteomics (2014) 1.42
Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2. J Immunol (2006) 1.42
The relationship between patient's perceived waiting time and office-based practice satisfaction. N C Med J (2007) 1.41
UniCarbKB: building a knowledge platform for glycoproteomics. Nucleic Acids Res (2013) 1.40
New urinary EPO drug testing method using two-dimensional gel electrophoresis. Clin Chim Acta (2005) 1.40
A role for macrophage inflammatory protein-3 alpha/CC chemokine ligand 20 in immune priming during T cell-mediated inflammation of the central nervous system. J Immunol (2003) 1.38
Determination of site-specific glycan heterogeneity on glycoproteins. Nat Protoc (2012) 1.38
Structural analysis of N- and O-glycans released from glycoproteins. Nat Protoc (2012) 1.36
Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells. Cancer Res (2006) 1.35
Development of a mass fingerprinting tool for automated interpretation of oligosaccharide fragmentation data. Proteomics (2004) 1.34
Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis (2006) 1.33
Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. Arthritis Rheum (2003) 1.32
Central role of manganese in regulation of stress responses, physiology, and metabolism in Streptococcus pneumoniae. J Bacteriol (2010) 1.32
Identification of two highly sialylated human tear-fluid DMBT1 isoforms: the major high-molecular-mass glycoproteins in human tears. Biochem J (2002) 1.32
Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrom Rev (2005) 1.26
GlycoSpectrumScan: fishing glycopeptides from MS spectra of protease digests of human colostrum sIgA. J Proteome Res (2010) 1.22
Transactivation of CXCR4 by the insulin-like growth factor-1 receptor (IGF-1R) in human MDA-MB-231 breast cancer epithelial cells. J Biol Chem (2005) 1.20
Enhanced CXC chemokine responses of human colonic epithelial cells to locus of enterocyte effacement-negative shiga-toxigenic Escherichia coli. Infect Immun (2003) 1.19
UniCarbKB: putting the pieces together for glycomics research. Proteomics (2011) 1.17
Negative ion graphitised carbon nano-liquid chromatography/mass spectrometry increases sensitivity for glycoprotein oligosaccharide analysis. Rapid Commun Mass Spectrom (2004) 1.16
Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer. Proteomics (2005) 1.15
Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells. Eur J Pharmacol (2004) 1.15
Toolboxes for a standardised and systematic study of glycans. BMC Bioinformatics (2014) 1.15
UniCarb-DB: a database resource for glycomic discovery. Bioinformatics (2011) 1.15
MIRAGE: the minimum information required for a glycomics experiment. Glycobiology (2014) 1.14
Regulation of chemotactic networks by 'atypical' receptors. Bioessays (2007) 1.14
A myriad of functions and complex regulation of the CCR7/CCL19/CCL21 chemokine axis in the adaptive immune system. Cytokine Growth Factor Rev (2013) 1.12
MALDI Imaging Mass Spectrometry (MALDI-IMS)-application of spatial proteomics for ovarian cancer classification and diagnosis. Int J Mol Sci (2011) 1.12
Site-specific glycoproteomics confirms that protein structure dictates formation of N-glycan type, core fucosylation and branching. Glycobiology (2012) 1.10
Up-regulation of CCR5 and CCR6 on distinct subpopulations of antigen-activated CD4+ T lymphocytes. J Immunol (2002) 1.10
Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/time-of-flight mass spectrometry. Rapid Commun Mass Spectrom (2006) 1.10
PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation. J Autoimmun (2011) 1.10
Quantitative N-linked glycoproteomics of myocardial ischemia and reperfusion injury reveals early remodeling in the extracellular environment. Mol Cell Proteomics (2011) 1.09
Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells. Int J Cancer (2010) 1.09
Site-specific glycan-peptide analysis for determination of N-glycoproteome heterogeneity. J Proteome Res (2013) 1.08
Glycosylation of sputum mucins is altered in cystic fibrosis patients. Glycobiology (2007) 1.07
Fragmentation behavior of glycated peptides derived from D-glucose, D-fructose and D-ribose in tandem mass spectrometry. J Mass Spectrom (2006) 1.06
Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis. Brain Pathol (2008) 1.06
Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro. J Virol (2008) 1.06
Sequential analysis of N- and O-linked glycosylation of 2D-PAGE separated glycoproteins. J Proteome Res (2003) 1.04
The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi. Blood (2013) 1.03
Total synthesis of homogeneous antifreeze glycopeptides and glycoproteins. Angew Chem Int Ed Engl (2012) 1.03
Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012. Mol Cell Proteomics (2013) 1.03
Leukocytes on the move with phosphoinositide 3-kinase and its downstream effectors. Bioessays (2005) 1.03
Structural determination of neutral O-linked oligosaccharide alditols by negative ion LC-electrospray-MSn. J Am Soc Mass Spectrom (2004) 1.02
Simple urinary sample preparation for proteomic analysis. J Proteome Res (2006) 1.01
Rat liver membrane glycoproteome: enrichment by phase partitioning and glycoprotein capture. J Proteome Res (2009) 1.01
Use of graphitised carbon negative ion LC-MS to analyse enzymatically digested glycosaminoglycans. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.00
Graphitized carbon LC-MS characterization of the chondroitin sulfate oligosaccharides of aggrecan. Anal Chem (2007) 1.00
Antibody immobilization within glass microstructured fibers: a route to sensitive and selective biosensors. Opt Express (2008) 1.00
Multiple functions of CXCL12 in a syngeneic model of breast cancer. Mol Cancer (2010) 1.00
Review of the predictive value of the Langendorff heart model (Screenit system) in assessing the proarrhythmic potential of drugs. J Pharmacol Toxicol Methods (2004) 1.00
Identification of glycan structure alterations on cell membrane proteins in desoxyepothilone B resistant leukemia cells. Mol Cell Proteomics (2011) 0.98
The glycosylation of human synovial lubricin: implications for its role in inflammation. Biochem J (2010) 0.97
Mini-review series: focus on chemokines. Immunol Cell Biol (2011) 0.97
A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutations. BMC Gastroenterol (2003) 0.96
Glycoproteomics of milk: differences in sugar epitopes on human and bovine milk fat globule membranes. J Proteome Res (2008) 0.95
Unseen proteome: mining below the tip of the iceberg to find low abundance and membrane proteins. J Proteome Res (2003) 0.94
Citric acid antigen retrieval (CAAR) for tryptic peptide imaging directly on archived formalin-fixed paraffin-embedded tissue. J Proteome Res (2010) 0.94
Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis. Oncotarget (2013) 0.94
Identification of a parathyroid hormone in the fish Fugu rubripes. J Bone Miner Res (2003) 0.94
MUC5B glycosylation in human saliva reflects blood group and secretor status. Glycobiology (2005) 0.94
Glycoform characterization of erythropoietin combining glycan and intact protein analysis by capillary electrophoresis - electrospray - time-of-flight mass spectrometry. Electrophoresis (2006) 0.93
Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans. Glycobiology (2012) 0.93
Liver membrane proteome glycosylation changes in mice bearing an extra-hepatic tumor. Mol Cell Proteomics (2010) 0.93
Proteomic characterization of mesenchymal stem cell-like populations derived from ovine periodontal ligament, dental pulp, and bone marrow: analysis of differentially expressed proteins. Stem Cells Dev (2010) 0.93
14-3-3:Shc scaffolds integrate phosphoserine and phosphotyrosine signaling to regulate phosphatidylinositol 3-kinase activation and cell survival. J Biol Chem (2009) 0.92
Comparative N-glycan profiling of colorectal cancer cell lines reveals unique bisecting GlcNAc and α-2,3-linked sialic acid determinants are associated with membrane proteins of the more metastatic/aggressive cell lines. J Proteome Res (2013) 0.92
Scientific review and recommendations on preclinical cardiovascular safety evaluation of biologics. J Pharmacol Toxicol Methods (2008) 0.92
Intraocular lens calculation accuracy limits in normal eyes. J Cataract Refract Surg (2008) 0.91
Imatinib as a potential antiresorptive therapy for bone disease. Blood (2006) 0.91
The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses. Blood (2010) 0.90
Challenges of determining O-glycopeptide heterogeneity: a fungal glucanase model system. Anal Chem (2010) 0.90
Finding their niche: chemokines directing cell migration in the thymus. Immunol Cell Biol (2010) 0.90
Investigation of the potential of clozapine to cause torsade de pointes. Adverse Drug React Toxicol Rev (2002) 0.90
Comparison of six immunohistochemical markers for the histologic diagnosis of neoplasia in Barrett's esophagus. Virchows Arch (2010) 0.89
Introducing glycomics data into the Semantic Web. J Biomed Semantics (2013) 0.89
Tandem mass spectra of glycan substructures enable the multistage mass spectrometric identification of determinants on oligosaccharides. Rapid Commun Mass Spectrom (2013) 0.89
The phosphoprotein StarD10 is overexpressed in breast cancer and cooperates with ErbB receptors in cellular transformation. Cancer Res (2004) 0.88
Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions. Biochem J (2005) 0.88
High throughput peptide mass fingerprinting and protein macroarray analysis using chemical printing strategies. Mol Cell Proteomics (2002) 0.88
A novel post-translational modification in nerve terminals: O-linked N-acetylglucosamine phosphorylation. J Proteome Res (2011) 0.88
Structural feature ions for distinguishing N- and O-linked glycan isomers by LC-ESI-IT MS/MS. J Am Soc Mass Spectrom (2013) 0.87
Radiative-surface plasmon resonance for the detection of apolipoprotein E in medical diagnostics applications. Nanomedicine (2012) 0.87